Metabolomic in Critical Ill Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Università Vita-Salute San Raffaele
ClinicalTrials.gov Identifier:
NCT01506674
First received: January 9, 2012
Last updated: April 4, 2014
Last verified: April 2014
  Purpose

Analysis of blood, urinary, and intrathecal metabolites of critical ill patients will be checked for possible correlations between metabolomics patterns and patients' outcomes.


Condition
Metabolomic

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Università Vita-Salute San Raffaele:

Study Start Date: January 2012
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
criticall ill patients

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Critical ill patients

Criteria

Inclusion Criteria:

  • patients with severe left or right ventricular dysfunction undergoing cardiac surgery
  • patients undergoing ablation of ventricular tachycardia
  • patients with febrile neutropenia after chemotherapy or allogeneic transplant for haematological diseases

Exclusion Criteria:

  • pregnant women
  • no written consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01506674

Locations
Italy
Università Vita-Salute San Raffaele
Milano, Mi, Italy, 20132
Sponsors and Collaborators
Università Vita-Salute San Raffaele
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01506674     History of Changes
Other Study ID Numbers: HSR CEmet
Study First Received: January 9, 2012
Last Updated: April 4, 2014
Health Authority: Italy: Ministry of Health

ClinicalTrials.gov processed this record on April 17, 2014